Subject(s)
Humans , Electrocardiography , Brugada Syndrome , Brugada Syndrome/therapy , Heart DiseasesABSTRACT
Um dos grandes desafios no atendimento dos pacientes nas unidades de emergência é o tratamento das arritmias ventriculares, principalmente, quando sustentadas e recorrentes, pois são de difícil tratamento e estão associadas à alta mortalidade. O principal mecanismo envolvido na sustentação das taquicardias ventriculares é o mecanismo de reentrada, devido às cicatrizes miocárdicas secundárias a diversas cardiopatias estruturais. A tempestade elétrica pode ser séria quando ocorre em portadores de desfibriladores automáticos, provocando múltiplos choques correspondentes fora do ambiente hospitalar. Nesses casos é necessária a internação hospitalar, onde medidas específicas e escalonadas de tratamento são realizadas, indo desde o manejo clínico até intervenções específicas, como programação de dispositivos eletrônicos, intervenções eletrofisiológicas ou cirúrgicas
One of the biggest challenges in the care of patients in emergency units is the treatment of ventricular arrhythmias, particularly when sustained and relapsing, as they are difficult to treat and are associated with high mortality. The main mechanism involved in the maintenance of ventricular tachycardias is the mechanism of reentry, due to myocardial scars secondary to various structural heart diseases. The electrical storm may be serious when it occurs in patients with automatic defibrillators, causing multiple corresponding shocks outside the hospital setting. In these cases, admission to hospital is necessary, where specific and stepwise treatment measures are performed, ranging from clinical management to specific interventions, such as programming of electronic devices, and electrophysiological or surgical interventions
Subject(s)
Humans , Male , Female , Pacemaker, Artificial , Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/therapy , Tachycardia, Ventricular/diagnosis , Tachycardia, Ventricular/therapy , Propranolol/therapeutic use , Quinidine/therapeutic use , Verapamil/therapeutic use , Electric Stimulation Therapy/methods , Defibrillators , Diagnosis, Differential , Electrocardiography/methods , Brugada Syndrome/diagnosis , Brugada Syndrome/therapy , Heart , Heart Diseases/diagnosis , Amiodarone/therapeutic useABSTRACT
As arritmias hereditárias são responsáveis por uma proporção significante de mortes cardíacas súbitas em indivíduos jovens aparentemente saudáveis. As canalopatias, como síndrome de Brugada, síndrome do QT longo/curto e taquicardia ventricular polimórfica catecolaminérgica, contribuem com essa incidência e não são marcadas por anomalias estruturais. A cardiomiopatia genética, como cardiomiopatia arritmogênica doventrículo direito e cardiomiopatia hipertrófica, também são causas de morte súbita por arritmia. Novos consensos têm sido publicados para orientar melhor as ferramentas dediagnóstico, os escores de estratificação e o tratamento. Os testes genéticos têm papel importante no diagnóstico, na estratificação de risco e no tratamento de pacientes e de suas famílias. Os avanços da genética molecular nas duas últimas décadas revelaram a base genética subjacente da doença, e podem levar a tratamentos mais personalizados...
Inherited arrhythmias account for a significant proportion of sudden cardiac deaths in apparently healthy and young individuals. Ion channelopathies such as Brugada syndrome, long/short QT syndrome and catecholaminergic polymorphic ventricular tachycardiacontribute to this incidence and are marked by no structural abnormalities. Genetic cardiomyopathy such as Right Ventricular Arrhythmogenic Cardiomyopathy and HypertrophicCardiomyopathy are also causes of arrhythmogenic sudden death. New consensuses are published to better guide the diagnostic tools, stratification scores and treatment. Genetic testing plays somehow an important role in the diagnosis, risk-stratification and treatment of patients and family members. Molecular genetic advances in the last 2 decades have revealed the underlying genetic basis and these may lead to a personalized medicine...
Subject(s)
Humans , Arrhythmias, Cardiac/genetics , Arrhythmias, Cardiac/therapy , Genetic Diseases, Inborn/therapy , Long QT Syndrome/diagnosis , Long QT Syndrome/genetics , Tachycardia, Ventricular/genetics , Tachycardia, Ventricular/therapy , Cardiomyopathy, Hypertrophic/therapy , Electrocardiography/methods , Propranolol , Sotalol/administration & dosage , Brugada Syndrome/diagnosis , Brugada Syndrome/therapy , Heart VentriclesABSTRACT
PURPOSE: Our study aims to analyze prognosis after implantable cardioverter-defibrillator (ICD) implantation in Korean patients with Brugada syndrome (BrS). MATERIALS AND METHODS: This was a retrospective study of BrS patients implanted with an ICD at one of four centers in Korea between January 1998 and April 2012. Sixty-nine patients (68 males, 1 female) were implanted with an ICD based on aborted cardiac arrest (n=38, 55%), history of syncope (n=17, 25%), or induced ven tricular tachyarrhythmia on electrophysiologic study in asymptomatic patients (n=14, 20%). A family history of sudden cardiac death and a spontaneous type 1 electrocardiography (ECG) were noted in 13 patients (19%) and 44 patients (64%), respectively. RESULTS: During a mean follow-up of 59+/-46 months, 4.6+/-5.5 appropri ate shocks were delivered in 19 patients (28%). Fourteen patients (20%) experienced 5.2+/-8.0 inappropriate shocks caused by supraventricular arrhythmia, lead failure, or abnormal sensing. Six patients were admitted for cardiac causes during follow-up, but no cardiac deaths occurred. An episode of aborted cardiac arrest was a significant predictor of appropriate shock, and the composite of cardiac events in the Cox pro portional hazard model [hazard ratio (95% confidence interval) was 11.34 (1.31-97.94) and 4.78 (1.41-16.22), respectively]. However, a spontaneous type 1 ECG was not a predictor of cardiac events. CONCLUSION: Appropriate shock (28%) and inappropriate shock (20%) were noted during a mean follow-up of 59+/-46 months in Korean BrS patients implanted with an ICD. An episode of aborted cardiac ar rest was the most powerful predictor of cardiac events.
Subject(s)
Adult , Female , Humans , Male , Middle Aged , Brugada Syndrome/therapy , Death, Sudden, Cardiac , Defibrillators, Implantable , Electrocardiography , Prognosis , Republic of Korea , Retrospective Studies , Treatment OutcomeABSTRACT
Desde su primera descripción el Sindrome de Brugada ha despertado gran interés científico como causa de muerte súbita. Presentamos el caso de un varón de 45 años quien ingresó al hospital en arresto cardiaco y en su evolución se le diagnosticó Sindrome de Brugada lográndose el implante de un cardiodesfibrilador como opción terapéutica definitiva. Resaltamos la importancia de reconocer el patrón electrocardiográfico característico y de considerar esta canalopatía en el diagnóstico diferencial de muerte súbita.
Since its first description the Brugada Syndrome has attracted great scientific interest because it is a cause ofsudden death. We show the case of a man 45 years old who arrived to our hospital in cardiac arrest. During hospitalization he was diagnosed with Brugada Syndrome. He received an implantable cardioverter-defibrillator as definitive treatment. We highlight the importance of being aware of the classic electrocardiographic pattern and considering this channelopathy in the differential diagnosis of cardiac arrest.